CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma

por Liu, Tingdang, Dai, Ximing, Xu, Yien, Guan, Tian, Hong, Liangli, Zaib, Tahir, Zhou, Qi, Cheng, Ke, Zhou, Xiaoling, Ma, Changchun, Sun, Pingnan
Publicado 2023

Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy

por Zaib, Tahir, Cheng, Ke, Liu, Tingdang, Mei, Ruyi, Liu, Qin, Zhou, Xiaoling, He, Lifang, Rashid, Hibba, Xie, Qingdong, Khan, Hanif, Xu, Yien, Sun, Pingnan, Wu, Jundong
Publicado 2023

Evaluation of multiple immune cells and patient outcomes in esophageal squamous cell carcinoma

por Wang, Hui, Su, Chanjuan, Li, Ziteng, Ma, Changchun, Hong, Liangli, Li, Zhe, Ma, Xiaonan, Xu, Yien, Wei, Xiaolong, Geng, Yiqun, Zhang, Weifeng, Li, Penghao, Gu, Jiang
Publicado 2023